|
|
|
|
LEADER |
01089cam#a2200325#a#4500 |
008 |
830202s1984####flua#####b####001#0#eng## |
005 |
20060804084933.0 |
001 |
BCCAB009411 |
003 |
AR-BCCAB |
245 |
1 |
0 |
|a Neutron activation analysis for clinical trace element research /
|c K. Heydorn.
|
260 |
# |
# |
|a Boca Raton, Fla. :
|b CRC Press,
|c c1984.
|
300 |
# |
# |
|a 2 v. :
|b il. ;
|c 27 cm.
|
020 |
# |
# |
|a 084935773X (v. 1)
|
020 |
# |
# |
|a 0849357748 (v. 2)
|
100 |
1 |
# |
|a Heydorn, K.
|
650 |
# |
0 |
|a Trace elements
|x Analysis.
|
650 |
# |
0 |
|a Nuclear activation analysis.
|
650 |
# |
0 |
|a Clinical chemistry
|x Technique.
|
650 |
# |
2 |
|a Activation analysis
|x Methods.
|
650 |
# |
2 |
|a Trace elements
|x Analysis.
|
010 |
# |
# |
|a ###83002685#
|
050 |
0 |
0 |
|a QP534
|b .H49 1984
|
060 |
# |
# |
|a QU 130 H615n
|
504 |
# |
# |
|a Incluye referencias bibliográficas.
|
040 |
# |
# |
|a DLC
|c DLC
|d DLC
|b spa
|d arbccab
|
500 |
# |
# |
|a Incluye indices.
|
082 |
0 |
0 |
|a 616.07/57
|2 19
|
942 |
# |
# |
|c BK
|
952 |
# |
# |
|2 udc
|a ARBCCAB
|b ARBCCAB
|i 14499
|o 543.53 H512 1 Vol.1
|p 14499
|t 1
|y BK
|
952 |
# |
# |
|2 udc
|a ARBCCAB
|b ARBCCAB
|i 14500
|o 543.53 H512 2 Vol.2
|p 14500
|t 2
|y BK
|